Medical Disclaimer & Legal Notice
PeptideStacks.co.uk is an educational research-literacy platform. It summarises published evidence, mechanisms, study models, regulatory context, and translational limitations for peptide-related research. It does not provide medical advice, dosing recommendations, sourcing advice, self-administration instructions, or protocols for human or animal use. This page combines the medical disclaimer with the full legal notice for the site.
Not medical advice
Nothing on PeptideStacks constitutes medical advice. No content is intended to diagnose, treat, cure, or prevent any disease or condition. No physician–patient relationship is created by reading this site. For any health concern, consult a qualified, registered healthcare professional in your jurisdiction.
Not veterinary advice
No content on this site is intended to instruct the administration of any compound to an animal. For animal health, consult a registered veterinary surgeon.
Not diagnosis or treatment
We do not diagnose disease. We do not recommend treatments. Where we describe mechanisms or study outcomes, those are descriptions of published evidence, not endorsements of use.
Not instructions for human or animal use
Many peptides discussed on this site are unapproved compounds in the UK. We do not publish instructions for their administration to humans or animals. Where doses appear in our content, they are reported in the context of published research — describing how a study investigator administered a compound to a research subject — not as recommendations.
Not for human consumption
The peptides discussed on this site have not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA), the European Medicines Agency, the U.S. Food and Drug Administration, or any equivalent regulatory body for human medicinal use, veterinary use, diagnostic use, food or cosmetic use, except where explicitly noted otherwise on the relevant peptide page (e.g. Tirzepatide / Semaglutide as licensed UK medicines). Unapproved compounds are intended exclusively for use as biochemical reference standards in licensed laboratory environments.
No clinical claims
Where this site describes effects of a peptide or stack, those descriptions reference observations recorded in published in vitro, ex vivo, or animal-model studies. They are not claims of efficacy or safety in humans. Where we summarise human pharmacokinetic studies (e.g. Phase I trials of GLP-1 agonists), we describe the published research record without endorsing extrapolation to non-clinical use.
No editorial supply, sourcing, or import advice
PeptideStacks does not provide editorial sourcing or import advice within its research content. Importation, supply, or administration of unapproved compounds may engage UK medicines law, customs law, controlled-substance law, or anti-doping rules. Those are matters for qualified professionals — not for a website.
PeptideStacks does carry clearly-labelled sponsor and sister-site placements — see our conflict-of-interest disclosure. Sponsor placements are not medical advice and do not constitute a recommendation to purchase or administer any compound. Sponsor placement is deliberately suppressed on peptide and stack pages whose subject is a UK prescription-only or POM-adjacent medicine.
Research-literacy framing
Where the site discusses peptides, GLP-1 agonists, or other compounds, the framing is research-literacy: we describe what is known, how confident the evidence base is, what the published doses or routes were in study contexts, and what is uncertain. This framing does not constitute permission, encouragement, or guidance to use any compound.
Regulatory and legal status
Specific peptides discussed on this site may fall under the Human Medicines Regulations 2012, the Misuse of Drugs Act 1971, the Psychoactive Substances Act 2016, the Veterinary Medicines Regulations, the World Anti-Doping Code, or sport-specific governing-body rules. It is the reader’s responsibility to verify the legal status of any compound in their own jurisdiction. We do not provide legal advice.
UK regulatory position
Under UK law, the peptides referenced here may only be purchased, stored and handled by competent laboratory researchers operating in a properly equipped laboratory environment. Importation, supply, or administration of these compounds to humans or animals outside a clinical trial authorised under the Medicines for Human Use (Clinical Trials) Regulations 2004 may constitute a criminal offence.
Specific peptides on this site may additionally fall under the Psychoactive Substances Act 2016, the Misuse of Drugs Act 1971, the Anti-Doping Rules under WADA, or sport-specific governing-body restrictions. It is the reader’s responsibility to verify the legal status of any compound in their own jurisdiction before any handling or research use.
Emergencies and adverse events
For a medical emergency, contact your local emergency services. In the UK that is 999 (life-threatening) or 111 (urgent but non-life-threatening). Suspected adverse reactions can be reported to the MHRA via the Yellow Card scheme. A clinician should be consulted for any concerning symptom.
Sponsor & sister-site disclosure
PeptideBarn.co.uk is a paid sponsor of PeptideStacks.co.uk (fixed-fee placement). Sponsor presence appears in the Footer, on the homepage, and in a labelled Sponsor panel at the bottom of unapproved-compound peptide and stack pages — and is deliberately suppressed on pages covering UK prescription-only or POM-adjacent medicines. PeptideAuthority.co.uk is a related editorial property (long-form per-peptide monographs); cross-links to that site appear in the same panels and from in-content references. The sponsorship and sister-site relationships do not influence evidence grades, citations, or safety framing on this site. For full detail see our conflict-of-interest disclosure.
Accuracy & revision
Peptide research is an active field. Although we revise pages as new literature emerges, study-context dose tables, timelines and safety summaries on this site may not reflect the most recent published research. Always cross-reference primary literature on PubMed or equivalent before acting on any claim. Material updates are logged in our evidence changelog.
Limitation of liability
To the maximum extent permitted by applicable law, PeptideStacks.co.uk, its operators, contributors, and affiliates accept no liability for any direct, indirect, incidental, consequential, special, or exemplary damages arising from the use of, or inability to use, the information presented on this website.